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LETTERS
Effect of Media 
Warnings on Rabies 
Postexposure 
Prophylaxis, France
To the Editor: Rabies was 
ofﬁ   cially declared eliminated in 
nonﬂ   ying mammals in metropolitan 
France during 2001–2008 by the World 
Organisation for Animal Health; the 
last case of rabies was believed to 
occur in a fox in 1998. However, rabies 
remained a public health concern 
because of the risk of translocation of 
infected dogs from enzootic areas and 
the natural circulation of bat rabies–
associated lyssaviruses (BRALVs). 
In 2008, France temporarily lost its 
rabies-free status following evidence 
of an indigenous case of rabies in 
a dog, linked to an index case in a 
dog infected in Morocco. In 2007, 
a domestic cat was found infected 
with a BRALV, an indication that, 
although bats are the primary hosts 
of this pathogen, other mammals may 
be infected. (1). Rabies is a tragic and 
frightening disease, and bats have a 
sinister image. Therefore, possible 
transmission of rabies from bats to 
humans represents a particularly 
terrifying threat in which emotional 
distortion may play a key role in 
public responses. Patient demand 
for rabies postexposure prophylaxis 
(RPEP) has been associated with 
media-communicated health alerts in 
France (2,3) and French Guiana (4).
We compared the number of 
RPEP treatments in humans after 
bat-related exposures in the south 
of France with newspaper reports 
about rabies-related events over an 
8-year period. In France, primary 
health care management of patients 
seeking RPEP is delivered through an 
ofﬁ  cial network of antirabies medical 
centers. All centers in the southern 
half of France were asked to provide 
the number of RPEP treatments that 
followed bat-related exposures in 
mainland France during 2002 through 
2009. Of 22 centers, 18 participated 
in the study, reporting 326 RPEP 
treatments (Figure). Two marked 
peaks were observed: in September 
2004 and in September 2008. The 
number of patients reporting bat-
related exposures that occurred during 
the summer period (June–September) 
showed marked annual variations 
with a 2.1-fold increase in 2004 (44 
cases) and a 4.7-fold increase in 2008 
(96 cases) compared with the 2002–
2009 average of 20.5 cases/summer 
(range 7–31). Most cases in 2008 
were reported by the Marseille and 
Bordeaux centers. In 2004, 3 cases 
of illegally imported dogs with rabies 
were observed in France, in February, 
May, and August (2,5). Newspapers 
reported extensively on the third 
case, with 54 articles published in 
the 3 major national newspapers 
(Le Monde, Le Figaro, Libération) 
(2), after an alert was issued in late 
August (Figure). On July 30, 2008, in 
response to a familial cluster of RPEP 
following bat bites near Marseille, 
a media-communicated health alert 
was organized by the Marseille center 
in the major regional newspaper 
(La Provence) to warn people about 
the potential risk of rabies after bat-
related exposures and the necessity 
of seeking advice when such events 
occur. The alert was developed by the 
Agence France Presse, released by 
the majority of national and regional 
newspapers, and included in a large 
number of websites (Figure). On 
August 28, 2008, an additional alert 
was released in Bordeaux because of 
2 BRALV-infected bats in the region 
(Figure). The alert was published in 
the regional newspaper (Sud-Ouest) 
(3). No other rabies-related events 
were intensively reported in French 
media during the study period.
The pattern of spikes in RPEP 
in the south of France seen after 
bat-rabies media reports supports 
the results of other studies that 
found effective newspaper reporting 
increases patient demand for RPEP 
(2–4). However, the increase is of 
short duration. Our results may 
indicate that media reports bring 
out the worried well who were not 
truly exposed but still request RPEP. 
The results may also indicate that 
bat-related injuries or contacts are 
underreported in the absence of 
media events. 
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Figure. Number of rabies postexposure prophylaxis treatments caused by bat-related 
exposures as reported by 18 antirabies medical centers in southern France, by time of ﬁ  rst 
visit, 2002–2009. Centers responding were Annecy, Annonay, Aurillac, Bastia, Bordeaux, 
Chambéry, Grenoble, Le Puy en Velay, Limoges, Lyon, Marseille, Nice, Pau, Perpignan, 
Poitiers, Roanne, Saint-Etienne, and Toulouse. LETTERS
Classical rabies virus has been 
transmitted to humans by bats in South 
America (6). In Europe, European 
bat lyssavirus type 1 (EBLV-1) has 
been isolated from bats in Germany, 
France, the Netherlands, Denmark, 
Yugoslavia, Spain, and Poland and 
EBLV-2 from bats in the Netherlands, 
United Kingdom, Switzerland, 
Germany, and Finland (6,7). Only 3 
cases of rabies in humans caused by 
bat bites have been reported in Europe 
(6). In France, health authorities 
recommend that all cases of conﬁ  rmed 
bat-related exposures (bites, scratches, 
exposures to a mucous membrane) 
receive RPEP with both vaccine and 
immunoglobulin (8), based on World 
Health Organization guidelines (9). 
Whether RPEF is needed for other 
types of exposures is subject to 
considerable debate (10). The centers 
in southern France are directed 
to provide RPEP only for known 
exposures. 
Based on results of study we 
conducted in 2008 when RPEP 
increased 4.7 fold after 2 media 
releases within several weeks, it is 
possible that only 20% of persons 
with bat exposure typically seek 
RPEP in periods without media 
reports. Although the risk of human 
rabies acquired through exposure to 
European bats is rare, information 
should be provided to the French 
public to avoid direct contact with bats, 
including handling when found inside 
homes during the summertime. When 
available, bats should be submitted for 
rabies testing to determine whether 
RPEP is needed. Following these 
procedures should minimize both 
the potential risk for transmission 
and the number of expensive RPEP 
treatments.
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Bedbugs as Vectors 
for Drug-Resistant 
Bacteria 
To the Editor: Over the past 10 
years in North America and western 
Europe, a resurgence of bedbugs 
(Cimex lectularius) has occurred (1). 
Although the basis for this resurgence 
is unclear, large bedbug infestations 
have been attributed to increased 
worldwide travel, altered insecticide 
management, and increased resistance 
to pesticides (2). Marginalized 
populations in large urban centers 
appear to be disproportionately 
affected; ≈30% of shelters in Toronto, 
Ontario, Canada, report bedbugs (1). 
We report recovery of methicillin-
resistant  Staphylococcus aureus 
(MRSA) and vancomycin-resistant 
Enterococcus faecium (VRE) from 
bedbugs in Vancouver, British 
Columbia.
Three patients, all residents of 
Vancouver’s Downtown Eastside—
an impoverished community in 
Vancouver with high rates of 
homelessness, poverty, HIV/AIDS, 
and injection drug use (3)—were 
hospitalized and found to be infested 
with bedbugs. Hypothesizing that 
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